期刊文献+

妊娠期糖尿病患者脂联素水平与胰岛素抵抗的关系 被引量:6

下载PDF
导出
摘要 目的分析脂联素(APN)与胰岛素抵抗(HOMA-IR)的关联性,探讨APN水平变化在妊娠期糖尿病中的发病机制,寻找早期诊断和防治妊娠期糖尿病的新途径。方法以孕中期糖筛查试验结果将病例分为3组:妊娠期糖尿病(GDM)组24例、妊娠期糖耐量受损(GIGT)组32例,正常糖耐量(GNGT)组30例作为对照组。分别记录3组病例在孕早中晚期的体重,空腹血糖、胰岛素,留置血清同批测定脂联素。根据空腹血糖和胰岛素水平计算胰岛素抵抗指数。结果 3组病例随着孕早中晚期孕程增加其APN水平各自均呈下降趋势,胰岛素抵抗指数(INR-IRI)呈上升趋势,同组相邻期间比较差异有统计学意义(P<0.05)。而在同一孕程,GDM组APN水平低于GIGT组、GNGT组,差异有显著性。GDM组APN水平与HOMA-IRI负相关。结论妊娠期糖尿病病人孕期,尤其是在孕早期即出现了APN水平显著下降,APN水平与HOMA-IRI呈负相关。APN对于妊娠期糖尿病的早期诊断、早期干预具有临床意义,早期补充外源性APN也是防治妊娠期糖尿病的一种探索。
作者 许青
出处 《海峡药学》 2012年第4期160-161,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献8

  • 1曹泽毅主编.妊娠期糖尿病,中华妇产科学(J).北京:人民卫生出版社,1999,514.
  • 2HaluzikM,Parizkova J,HaluzikMM,et al.Adiponmtin and Its Role inthe Obesity-Induced InsulinResistance and Related Complications(J).Physiol Res,2004.53(2):123.
  • 3张木勋,杨雁,Katherine Cianflone,余海英,张建华,王宏伟,卢慧玲.2型糖尿病患者和甲状腺疾病患者血浆脂联素水平变化[J].中华内分泌代谢杂志,2005,21(1):59-60. 被引量:13
  • 4Vasseur F,Helbecque N.Dina C,et al.Single-nucleotide polymor-phism haplotypes in the both proximal promoter and exon 3 of theAPM I gene modulate adipocyte-secreted adiponectin hormone levelsand contribute to the genetic risk for type 2 diabetes in French Cau-casians(J).Human Molecular Genetics,2002,11(21):2607.
  • 5Yamauchi T,Kamon J,Minokoshi Y,et al.Adiponectin stimulatesglucose utilization and fatty-acidoxidation by activating AMP-activatedprotein kinase(J).Nature Med,2002,8(11):1288-1295.
  • 6刘楼,许建娟.妊娠期糖尿病孕妇血清脂联素表达的相关性研究[J].实用临床医药杂志,2007,11(1):89-90. 被引量:7
  • 7Buchanan TA,Xiang A,Kjos SL,et al.Gestational diabetes:antepar-tum characteristics that predict postpartum gluose intolerance and type2 diabetes in Latino women(J).Diabetes,1998,47:1302-1310.
  • 8Retnakaran R,Hanley AJ,Raif N,et al.Reduced adiponectin concen-tration in women with gestational diab etes:a potential factor in pro-gression to type 2 diabetes(J).Diabetes Care,2004,27(3):799-800.

二级参考文献16

  • 1Faraj M, Havel PJ, Phelis S, et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab, 2003,88:1594-1602.
  • 2Maeda N, Takashi M, Funahashi T, et al. PPAR-γ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001,50:2094-2099.
  • 3Hotta K, Funahashi T, Arita Y, et al. Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 2000,20:1595-1599.
  • 4Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes, 2003,52:239-243.
  • 5Stefan N, Stumvoll M. Adiponectin: its role in metabolism and beyond. Horm Metab Res, 2002,34:469-474.
  • 6Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in Pima Indian population. Lancet, 2002,360:57-58.
  • 7Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol, 1998,8:335-338.
  • 8Chandran M,Susan A,Theodore C,et al.Adiponetin:More than just another fat cell Hormone[J].Diabetes Care,2003,26(8):2442.
  • 9Haluzik M,Parizkova J,Haluzik M M,et al.Adiponectin and Its Role in the Obesity-Induced InsulinResistance and Related Complications[J].Physiol Res,2004,53(2):123.
  • 10Vasseur F,Helbecque N,Dina C,et al.Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians[J].Human Molecular Genetics,2002,11(21):2607.

共引文献18

同被引文献112

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部